PT3144676T - Kit compreendendo anticorpo que se liga especificamente à proteína de fator b do complemento e anticorpo que se liga especificamente à proteína do antigénio carboidrato 19-9 para diagnosticar o cancro pancreático - Google Patents

Kit compreendendo anticorpo que se liga especificamente à proteína de fator b do complemento e anticorpo que se liga especificamente à proteína do antigénio carboidrato 19-9 para diagnosticar o cancro pancreático

Info

Publication number
PT3144676T
PT3144676T PT148920291T PT14892029T PT3144676T PT 3144676 T PT3144676 T PT 3144676T PT 148920291 T PT148920291 T PT 148920291T PT 14892029 T PT14892029 T PT 14892029T PT 3144676 T PT3144676 T PT 3144676T
Authority
PT
Portugal
Prior art keywords
protein
specifically binding
antibody specifically
kit
pancreatic cancer
Prior art date
Application number
PT148920291T
Other languages
English (en)
Original Assignee
Jw Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54480106&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3144676(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jw Holdings Corp filed Critical Jw Holdings Corp
Publication of PT3144676T publication Critical patent/PT3144676T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Electrochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
PT148920291T 2014-05-12 2014-09-03 Kit compreendendo anticorpo que se liga especificamente à proteína de fator b do complemento e anticorpo que se liga especificamente à proteína do antigénio carboidrato 19-9 para diagnosticar o cancro pancreático PT3144676T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140056585A KR20150129932A (ko) 2014-05-12 2014-05-12 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트

Publications (1)

Publication Number Publication Date
PT3144676T true PT3144676T (pt) 2020-03-23

Family

ID=54480106

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148920291T PT3144676T (pt) 2014-05-12 2014-09-03 Kit compreendendo anticorpo que se liga especificamente à proteína de fator b do complemento e anticorpo que se liga especificamente à proteína do antigénio carboidrato 19-9 para diagnosticar o cancro pancreático

Country Status (10)

Country Link
US (1) US10656154B2 (pt)
EP (1) EP3144676B1 (pt)
JP (1) JP6361943B2 (pt)
KR (1) KR20150129932A (pt)
CN (1) CN106461665B (pt)
DK (1) DK3144676T3 (pt)
ES (1) ES2776733T3 (pt)
PL (1) PL3144676T3 (pt)
PT (1) PT3144676T (pt)
WO (1) WO2015174585A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2140269T3 (da) 2007-03-27 2013-12-16 Immunovia Ab Proteinsignatur/markører til at detektere adenocarcinom
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
KR102289278B1 (ko) * 2019-07-09 2021-08-13 주식회사 베르티스 췌장암 진단용 바이오마커 패널 및 그 용도
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63159763A (ja) * 1986-12-24 1988-07-02 Fujirebio Inc 逆受身凝集反応試薬
AU2003294828A1 (en) 2002-12-17 2004-07-09 Sinogenomax Co. Ltd. Chinese National Human Genomecenter Specific markers for pancreatic cancer
CN1726395A (zh) * 2002-12-17 2006-01-25 北京诺赛基因组研究中心有限公司 胰腺癌的特异标记
JP2007051880A (ja) * 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
EP1991872A1 (en) * 2006-03-02 2008-11-19 Oncotherapy Science, Inc. Methods for diagnosing pancreatic cancer using reg4 protein
DK2140269T3 (da) * 2007-03-27 2013-12-16 Immunovia Ab Proteinsignatur/markører til at detektere adenocarcinom
EP2331134A4 (en) * 2008-08-08 2014-10-15 Immunomedics Inc ANTI-PANCREAS CANCER ANTIBODY
MX341517B (es) * 2010-08-13 2016-08-24 Somalogic Inc Biomarcadores de cancer pancreatico y usos de los mismos.
GB201103726D0 (en) * 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
TWI408370B (zh) * 2011-05-19 2013-09-11 Univ Chang Gung 胰臟癌之血清生物檢測標誌及其應用
KR101358510B1 (ko) * 2011-09-28 2014-02-06 사회복지법인 삼성생명공익재단 카텝신 ｄ와 매트릭스 메탈로프로틴나제-7의 측정수단을 포함하는 췌장암 진단용 키트
KR101384211B1 (ko) * 2012-03-19 2014-04-14 서울대학교산학협력단 췌장암 진단용 마커 및 이의 용도
JP2014020930A (ja) * 2012-07-18 2014-02-03 Kanazawa Univ 膵癌診断及び治療効果予測判定バイオマーカー

Also Published As

Publication number Publication date
WO2015174585A1 (ko) 2015-11-19
EP3144676B1 (en) 2019-12-11
CN106461665A (zh) 2017-02-22
JP2017526896A (ja) 2017-09-14
CN106461665B (zh) 2019-01-25
JP6361943B2 (ja) 2018-07-25
US20170153239A1 (en) 2017-06-01
PL3144676T3 (pl) 2020-07-13
ES2776733T3 (es) 2020-07-31
EP3144676A4 (en) 2017-09-27
US10656154B2 (en) 2020-05-19
EP3144676A1 (en) 2017-03-22
KR20150129932A (ko) 2015-11-23
DK3144676T3 (da) 2020-03-16
CN106461665A8 (zh) 2017-06-30

Similar Documents

Publication Publication Date Title
IL259643A (en) Antibodies and antibody fragments for site-specific conjugation
HRP20181802T1 (hr) Protutijela koja vežu humani cd3
HK1225641A1 (zh) Gitr抗原結合蛋白
DK3182999T3 (da) Anti-lag3-antistoffer og antigenbindingsfragmenter
HK1238648A1 (zh) 與pd-1 結合的抗原結合蛋白
IL260846B (en) Antigen binding proteins that bind pd-l1
ZA201701912B (en) Antigen binding proteins that bind cxcr5
HK1259325A1 (zh) 澱粉樣蛋白β中的N-末端表位及其構象選擇性抗體
HK1231497A1 (zh) 表現不同結合特徵的 抗原結合蛋白
EP3374380A4 (en) C-TERMINAL EPITOPES IN BETA-AMYLOID AND RELATED CONFORMATIONAL ANTIBODIES
EP3374382A4 (en) BETA-AMYLOID EPITOPES AND ASSOCIATED SELECTIVE CONFORMATIONAL ANTIBODIES
ZA202000851B (en) Antibodies useful in cancer diagnosis
ZA201701941B (en) Antigen binding proteins that bind cxcr3
PT3144676T (pt) Kit compreendendo anticorpo que se liga especificamente à proteína de fator b do complemento e anticorpo que se liga especificamente à proteína do antigénio carboidrato 19-9 para diagnosticar o cancro pancreático
ZA201906821B (en) Anti-jagged1 antigen binding proteins
EP3444273A4 (en) ANTIBODY BINDING SPECIFICALLY TO AIMP2-DX2 PROTEIN
SG11201703292VA (en) ANTI HUMAN Gas6 MONOCLONAL ANTIBODY
EP3444279C0 (en) ANTIBODIES WITH IMPROVED STABILITY AND SPECIFIC BINDING TO HER2
GB201415714D0 (en) Antibodies and antigen binding fragments thereof
GB201614627D0 (en) Antigen binding proteins
DK3288978T3 (da) IGF-1R-antistof og dets anvendelse til cancerdiagnose
GB201306091D0 (en) Combination of at least two tumour associated antigen (TAA)-binding antibodies or binding fragments thereof